Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABAX
1401
DELISTED
Abaxis Inc
ABAX
| $4.97M | 0.01% |
+96,509
| New | +$5.43M |
|
1402
RPC Inc
RES
$1.36B
| $4.96M | 0.01% |
358,879
-2,068,358
| -85% | -$30.5M |
|
|
SN
1403
DELISTED
Sanchez Energy Corporation
SN
| $4.96M | 0.01% |
+506,038
| New | +$6.12M |
|
1404
Nektar Therapeutics
NKTR
$2.56B
| $4.94M | 0.01% |
26,340
-30,226
| -53% | -$5.2M |
|
|
EPE
1405
DELISTED
EP Energy Corporation
EPE
| $4.94M | 0.01% |
388,181
-582,003
| -60% | -$7.74M |
|
1406
Innospec
IOSP
$2.32B
| $4.93M | 0.01% |
109,556
+47,875
| +78% | +$2.15M |
|
1407
Open Text
OTEX
$5.9B
| $4.93M | 0.01% |
243,472
-422,144
| -63% | -$10.2M |
|
|
NEWP
1408
DELISTED
NEWPORT CORP
NEWP
| $4.93M | 0.01% |
259,910
+44,042
| +20% | +$854K |
|
1409
Universal Corp
UVV
$1.14B
| $4.92M | 0.01% |
85,758
-47,729
| -36% | -$2.41M |
|
1410
PUT
Melco Resorts & Entertainment
MLCO
$2.08B
| $4.91M | 0.01% |
+250,000
| New | +$5.15M |
|
|
MNDT
1411
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $4.89M | 0.01% |
100,000
+94,200
| +1,624% | +$4.27M |
|
1412
Boise Cascade
BCC
$2.83B
| $4.89M | 0.01% |
133,278
-393,589
| -75% | -$14.4M |
|
|
IMMU
1413
CALL
DELISTED
Immunomedics Inc
IMMU
| $4.87M | 0.01% |
1,200,000
+700,000
| +140% | +$2.86M |
|
1414
CALL
Deere & Co
DE
$170B
| $4.85M | 0.01% |
50,000
| – | – |
|
|
PTX
1415
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $4.85M | 0.01% |
81,962
+35,969
| +78% | +$2.54M |
|
1416
ConocoPhillips
COP
$158B
| $4.85M | 0.01% |
+78,915
| New | +$5.14M |
|
|
ATVI
1417
CALL
DELISTED
Activision Blizzard
ATVI
| $4.84M | 0.01% |
+200,000
| New | +$4.88M |
|
|
GRMN
1418
Garmin
GRMN
$55.6B
| $4.84M | 0.01% |
110,189
+86,975
| +375% | +$4.01M |
|
|
EVER
1419
DELISTED
Everbank Financial Corp
EVER
| $4.84M | 0.01% |
+246,251
| New | +$4.61M |
|
|
BKS
1420
DELISTED
Barnes & Noble
BKS
| $4.83M | 0.01% |
283,928
-391,194
| -58% | -$6.11M |
|
1421
FS KKR Capital
FSK
$3.33B
| $4.83M | 0.01% |
122,683
+56,662
| +86% | +$2.34M |
|
1422
MacroGenics
MGNX
$266M
| $4.82M | 0.01% |
126,817
+92,912
| +274% | +$3.05M |
|
|
UNT
1423
DELISTED
UNIT Corporation
UNT
| $4.81M | 0.01% |
177,363
-396,696
| -69% | -$12.5M |
|
|
STRZA
1424
DELISTED
Starz - Series A
STRZA
| $4.81M | 0.01% |
107,533
+98,823
| +1,135% | +$3.93M |
|
1425
Dorian LPG
LPG
$2.17B
| $4.8M | 0.01% |
287,743
+26,407
| +10% | +$373K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.